In 2025, a staggering 99% of FDA warning letters issued to regulated laboratories contained citations
Learn More In 2025, a staggering 99% of FDA warning letters issued to regulated laboratories contained citations
Learn More
Research from the Standish Group found that only 31% of software projects fully meet their
Learn More
A New Regulatory Blueprint for AI In January 2026, the U.S. Food and Drug
Learn More
Biopharma executives report that digitizing and automating quality control lab operations can reduce compliance issues
Learn More
In this blog, we explore the full stack of clinical research technology in 2026. Clinical
Learn More
How next-generation clinical trials will operate from one curated view of trial health. Data quality
Learn More
AI adoption across healthcare and life sciences organizations has risen to 70%, up from 63%
Learn More
In 2025, the FDA issued 470 warning letters; a staggering 99% of these actions cited
Learn More
The life sciences industry is at a critical inflection point in 2026, as the limitations
Learn More How LabVantage LIMS Enables Consistent, Connected, and Context-Rich Scientific Data Artificial intelligence is now integral
Learn More
Unplanned downtime in a life sciences environment is more than an IT disruption. It creates
Learn More
In fiscal year 2023, the FDA issued more than 3,800 Form 483 observations, many tied
Learn More
Type your paragraph here
